Journal ArticleOPEN ACCESS

Interferon-α may help prevent molecular relapse of chronic myeloid leukemia after the discontinuation of tyrosine kinase inhibitors

  • Jun K
  • Ya-zhen Q
  • Xiao-su Z
  • et al.
Therapeutic Advances in Hematology (2021) 12
DOI: 10.1177/2040620720986643
N/ACitations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background:Currently, the goal of chronic myeloid leukemia (CML) treatment is normal survival and good quality of life without life-long treatment, namely, “treatment-free remission” (TFR). At pres...

Cite

CITATION STYLE

APA

Jun, K., Ya-zhen, Q., Xiao-su, Z., Hong-Xia, S., Yue-Yun, L., Kai-yan, L., … Hao, J. (2021). Interferon-α may help prevent molecular relapse of chronic myeloid leukemia after the discontinuation of tyrosine kinase inhibitors. Therapeutic Advances in Hematology, 12. https://doi.org/10.1177/2040620720986643

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free